|  |  | ER Positive Model |  |  |  | ER Negative Model |  |
---|---|---|---|---|---|---|---|---|
Prognostic Factor | Hazard ratio | 95% CI | Coefficient | SE | Hazard ratio | 95% CI | Coefficient | SE |
Number Positive Nodes* | Â | Â | Â | Â | Â | Â | Â | Â |
   (0, 1, 2 to 4, 5 to 9, 10+) | 1.75 | 1.62 to 1.89 | 0.56 | 0.04 | 1.55 | 1.44 to 1.68 | 0.44 | 0.04 |
Tumour Size, mm* | Â | Â | Â | Â | Â | Â | Â | Â |
   (<10, 10 to 19, 20 to 29, 30 to 49, 50+) | 1.43 | 1.30 to 1.58 | 0.36 | 0.05 | 1.45 | 1.29 to 1.63 | 0.37 | 0.06 |
Tumour Grade* | 1.43 | 1.30 to 1.58 | 0.36 | 0.05 | 1.45 | 1.29 to 1.63 | 0.37 | 0.06 |
   (Low, Intermediate, High) | 1.43 | 1.30 to 1.58 | 0.36 | 0.05 | 1.45 | 1.29 to 1.63 | 0.37 | 0.06 |
Detection by Screening | 0.70 | 0.53 to 0.92 | -0.36 | 0.14 | 0.86 | 0.56 to 1.32 | -0.15 | 0.22 |
Chemotherapy | 0.73 | 0.60 to 0.89 | -0.31 | 0.1 | 0.82 | 0.62 to 1.08 | -0.2 | 0.14 |
Hormone therapy | 0.95 | 0.74 to 1.23 | -0.05 | 0.13 | 1.43 | 1.09 to 1.89 | 0.36 | 0.14 |